Taipei: Taiwan-based Formosa Pharmaceuticals has announced an exclusive licensing agreement with Cipla Limited for the commercialization of clobetasol propionate ophthalmic suspension, 0.05% (APP13007 ...
Cipla has announced an exclusive licensing agreement with Taiwan-based Formosa Pharmaceuticals to market clobetasol propionate ophthalmic suspension 0.05% (APP13007) across 11 countries, including ...
Cipla Limited on Tuesday announced an exclusive licensing agreement with Taiwan-based Formosa Pharmaceuticals for the commercialization of clobetasol propionate ophthalmic suspension, 0.05% ...
"Formosa Pharma welcomes this partnership with Cipla, a well-renowned and respected global pharmaceutical brand. We appreciate their recognition and desire to add APP13007 to their rich portfolio ...
Cipla is currently trading at Rs 1493.25, showing a notable increase of 2.15% today, with a 3-day exponential moving average of Rs 1416.95. Cipla is currently trading at Rs 1488.65, indicating a 1.83% ...
The newly released Ninja Swirl by Creami is making a huge splash in the ice cream world and I've found the best place for it: the office. After all, nothing helps boost company morale better ...
Thanks to a patented Alpha-3 Peptide, this cream works to improve elasticity and lift the skin. Additionally, it includes brightening clary sage extract and antioxidant-rich spilanthol to reduce ...
Cipla's current price stands at Rs 1429.0, reflecting a 1.95% rise today, while its three-month returns have dipped by 4.53%. Cipla has achieved a positive price breakout and is trading above its ...
Explore Cipla stock price history with detailed daily historical prices, including open, high, low, and volume data. Review stock chart history to analyze past trends and find the highest Cipla price.
Since celebrating a milestone birthday (yay!), I've started to notice a few fine lines and wrinkles that weren't on my face the previous year (ugh!). A great wrinkle cream helps hydrate and plump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results